Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Endoscopic ultrasound in suspected biliary obstruction influences ERCP burden in real clinical practice

A study in this month's issue of the European Journal of Gastroenterology & Hepatology reports on the diagnostic accuracy of endoscopic ultrasound in suspected biliary obstruction and its impact on ERCP burden in real clinical practice.

News image

Performing endoscopic ultrasound before endoscopic retrograde cholangiopancreatography (ERCP) has been described to be useful in cases of suspected biliary obstruction where endoscopic ultrasound can triage patients for endoscopic retrograde cholangiopancreatography.

Dr Zaheer Abdula and colleagues determined the diagnostic accuracy of endoscopic ultrasound and its impact on endoscopic retrograde cholangiopancreatography burden in real clinical practice.

The research team evaluated the safety and efficacy of endoscopic ultrasound+endoscopic retrograde cholangiopancreatography in a single endoscopic session.

The team evaluated 418 consecutive patients with suspected but unexplained biliary obstruction referred for endoscopic ultrasound before possible endoscopic retrograde cholangiopancreatography.

The research team team determined the diagnostic accuracy of endoscopic ultrasound and its value in predicting the need for endoscopic retrograde cholangiopancreatography.

Endoscopic ultrasound established whether pancreaticobiliary disorder was present, and whether therapeutic endoscopic retrograde cholangiopancreatography was required.

Endoscopic ultrasound showed pathology in 42% who had a nondilated biliary system
European Journal of Gastroenterology & Hepatology

These decisions were matched with endoscopic retrograde cholangiopancreatography findings, histology, clinical course, and follow-up.

Where endoscopic retrograde cholangiopancreatography was indicated, it was performed in the same endoscopic session.

Endoscopic ultrasound was performed in 412 out of 418 patients, and endoscopic retrograde cholangiopancreatography was considered necessary in 64%.

The research team noted that the single-session endoscopic ultrasound, and endoscopic retrograde cholangiopancreatography was safe and effective.

The diagnostic accuracy of endoscopic ultrasound included 99% in choledocholithiasis, 90% with malignant strictures, and 92% with benign strictures.

The research team reported that endoscopic ultrasound showed pathology in 42% of patients who had a nondilated biliary system at initial investigations.

When endoscopic ultrasound indicated a normal common bile duct, this had a 100% positive predictive value for non-necessity for endoscopic retrograde cholangiopancreatography.

The median overall follow-up period was 12 months.

Dr Abdula's team commented, "Endoscopic ultrasound demonstrated high diagnostic accuracy in this mixed group of pancreaticobiliary disorder."

"This accurately guided endoscopic retrograde cholangiopancreatography need and avoided unnecessary endoscopic retrograde cholangiopancreatography in 36%."

"endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the same endoscopic session for the evaluation and management of PBD is technically feasible, with safety and efficacy profiles equivalent to that of each procedure performed independently in different sessions."

Eur J of Gastroenterol & Hepatology: 2013: (25)7 :850-857
21 June 2013

Go to top of page Email this page Email this page to a colleague

 27 March 2015

Advanced search
 27 March 2015 
Screening for fecal incontinence
 27 March 2015 
Deep remission in Crohn's disease
 27 March 2015 
Sexual functioning in IBD
 26 March 2015 
Antimicrobial therapy in cirrhosis with spontaneous bacterial peritonitis
 26 March 2015 
Metformin as a chemopreventive agent for Barrett's
 26 March 2015 
Survival of untreated hepatocellular carcinoma
 25 March 2015 
Genetics and Crohn's disease
 25 March 2015 
Mortality in Barrett’s–related T1 esophageal adenocarcinoma
 25 March 2015 
Cytomegalovirus and IBD
 24 March 2015 
Prevention of colorectal cancer after screening
 24 March 2015 
Functional GI disorders and body mass index
 24 March 2015 
Quality of life in children with fecal incontinence
 23 March 2015 
Fibrosis in NAFLD vs NASH
 23 March 2015 
The unmasking of Whipple's disease
 23 March 2015 
Predicting the quality of colon cancer care
 20 March 2015 
Interventions for eosinophilic esophagitis
 20 March 2015 
Colorectal cancer risk and genetic variants
 20 March 2015 
Screening for Barrett's esophagus
 19 March 2015 
Hypnotherapy for IBS
 19 March 2015 
Poor mental and physical health in HCV
 19 March 2015 
Dedicated care for diverticular disease
 18 March 2015 
Practice guidelines for colorectal polyps
 18 March 2015 
Out-of-hours endoscopy for upper GI bleeding
 18 March 2015 
H. pylori eradication and lipids
 17 March 2015 
H. pylori test-and-treat program and gastric cancer
 17 March 2015 
Adalimumab in Crohn’s disease
 17 March 2015 

Low-dose PPIs and GI bleeding in patients receiving aspirin

 16 March 2015 
Microscopic colitis
 16 March 2015 
Cholestasis of pregnancy with HCV
 16 March 2015 
Hybrid therapy for H. pylori
 13 March 2015 
Medicare patients and payments to gastroenterologists
 13 March 2015 
Appendectomy in ulcerative colitis
 13 March 2015 

Racial disparities in gluten-sensitive problems

 12 March 2015 
Predicting IBD in IBS patients
 12 March 2015 
Patient knowledge of IBS
 12 March 2015 
Nonceliac gluten sensitivity
 11 March 2015 

Prediction of malignant bile duct obstruction

 11 March 2015 
NAFLD–related hepatocellular carcinoma
 11 March 2015 
Assessment of eosinophilic esophagitis
 10 March 2015 
Risk for gastroesophageal reflux symptoms
 10 March 2015 
Poor disease course in pediatric ulcerative colitis
 10 March 2015 
Outcomes in Crohn's therapy
 09 March 2015 
Fibre usage in ulcerative colitis in remission
 09 March 2015 
Gastric Cancer detection during GI endosocopy
 09 March 2015 
Risk of C. difficile upon hospital admission
 06 March 2015 
Second anti-TNF in IBD
 06 March 2015 
Efficacy of Hep E vaccine
 06 March 2015 
Steroid therapy for eosinophilic esophagitis
 05 March 2015 
EPHXI polymorphism and esophageal cancer risk
 05 March 2015 
Infliximab and immunosuppressant therapy in ulcerative colitis
 05 March 2015 
Neuroendocrine carcinoma of the colon and rectum
 04 March 2015 
Multidisciplinary management of rectal cancer
 04 March 2015 
Management of IBD
 04 March 2015 
Progression of Barrett's
 03 March 2015 
EPHX1 polymorphism and esophageal cancer risk
 03 March 2015 
GI bleeding in chronic kidney disease patients on aspirin
 03 March 2015 
Risk of anastomotic leak after colectomy
 02 March 2015 
Genes and early diagnosis of IBD
 02 March 2015 
Assessment of GERD
 02 March 2015 
Liver disease in patients awaiting liver transplant

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us